Granules India hosts analyst meet on September 18 in Hyderabad

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Granules India hosts analyst meet on September 18, 2026
  • Session held in Hyderabad per SEBI LODR Regulation 30
  • No unpublished price-sensitive info to be shared
  • Schedule is tentative and subject to change
powered bylight_fuzz_icon
50669068

*this image is generated using AI for illustrative purposes only.

Granules India Limited will host a meeting with analysts, investors, and funds in Hyderabad on September 18, 2026. The session is part of the company's regular engagement with the investment community.

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Chaitanya Tummala, Company Secretary and Compliance Officer, confirmed the schedule on September 11, 2026.

Meeting Details

The management team will address queries from the investment community. The company stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during the meeting.

The schedule remains tentative and may be subject to changes due to difficulties faced by the company or the participants. Investors seeking updated financial information can access the latest investor presentation on the company’s website.

Regulatory Compliance

Granules India Limited is listed on both the National Stock Exchange of India Limited and BSE Limited. The disclosure ensures transparency and equal access to information for all stakeholders as mandated by securities regulations.

Historical Stock Returns for Granules

1 Day5 Days1 Month6 Months1 Year5 Years
+1.12%+6.49%+6.33%+56.43%+73.32%0.0%

How might the management's responses to investor queries during this meeting influence Granules India's stock valuation in the near term?

What specific strategic initiatives or pipeline developments is the company likely to emphasize to attract institutional funds given the current pharma market climate?

Could this engagement signal an upcoming material corporate action, such as a rights issue or dividend revision, despite the disclaimer on unpublished price-sensitive information?

Granules India transfers CSO Sanjay Kumar to subsidiary CEO role

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Granules India Limited transferred Mr. Sanjay Kumar from Chief Strategy Officer to CEO of its subsidiary, Ascelis Peptides Private Limited, effective August 13, 2026. The move aims to provide dedicated leadership for the subsidiary's complex operations. The change was disclosed under SEBI Regulation 30.

powered bylight_fuzz_icon
48160995

*this image is generated using AI for illustrative purposes only.

Granules India Limited has announced the internal transfer of Mr. Sanjay Kumar, Chief Strategy Officer and Senior Management Personnel (SMP), to its wholly owned subsidiary, Ascelis Peptides Private Limited. The transition takes effect on August 13, 2026, with Mr. Kumar assuming the role of Chief Executive Officer at the subsidiary.

The company stated that this move reflects its view that a business of such scale, ambition, and complexity requires dedicated leadership with clear accountability. Mr. Kumar tendered his resignation from the position of Chief Strategy Officer at Granules India Limited on August 12, 2026, pursuant to this internal transfer decision by the management.

Regulatory Disclosure

The intimation was issued pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Particulars Details
Name of SMP Mr. Sanjay Kumar
Reason for Change Resignation due to internal transfer to wholly owned subsidiary
Effective Date August 13, 2026
New Role Chief Executive Officer, Ascelis Peptides Private Limited

Mr. Kumar expressed appreciation for the support and guidance extended by the Board of Directors, the Chairman & Managing Director, and the leadership team during his tenure as Chief Strategy Officer. The Company Secretary and Compliance Officer, Chaitanya Tummala, confirmed the details in the filing.

Historical Stock Returns for Granules

1 Day5 Days1 Month6 Months1 Year5 Years
+1.12%+6.49%+6.33%+56.43%+73.32%0.0%

How will the leadership vacuum at Granules India Limited's Chief Strategy Officer role be filled, and will this impact the parent company's strategic roadmap?

What specific growth initiatives or operational challenges at Ascelis Peptides Private Limited prompted the need for dedicated CEO-level leadership?

Will Mr. Sanjay Kumar retain any advisory or board-level responsibilities with Granules India Limited while serving as CEO of the subsidiary?

More News on Granules

1 Year Returns:+73.32%